High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme
Muhammad Kamil(Kagoshima University), Kazunori Arita(Kagoshima University)
Cited by 46
Related Papers
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
|Oncotarget|2013|78
Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report
|Molecular and Clinical Oncology|2017|4